Sunday, September 13, 2026

US CLARITY Act targets North Korea’s Lazarus with preemptive asset freeze powers

The U.S. Senate's proposed CLARITY Act aims to curb North Korea's crypto activities, granting the Treasury powers to freeze suspicious transactions.

North Korea Condemns RIMPAC Exercise Led by South Korea, Calls It “Demonstration of War of Aggression”

North Korea criticizes US-ROK-Japan military cooperation as a "new security crisis" in the Asia-Pacific, threatening a new level of deterrence.

Fire on Air Busan Flight at Gimhae Airport Fully Extinguished, All 176 Passengers Safely Evacuated

A fire on an Air Busan aircraft at Gimhae Airport led to an emergency evacuation of 176 people, with minor injuries reported.

Tag: Samsung Biologics

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Samsung Biologics Launches 3 Billion USD Stock Offering to Acquire Polypeptide Group: What This Means for the Global CDMO Market

Samsung Biologics plans a 2.3 billion USD capital increase to become a top-tier CDMO, primarily for acquiring Polypeptide Group.

Samsung Biologics’ Q2 Success: 30% Revenue Growth and Global Expansion Plans

Samsung Biologics exceeded Q2 market expectations due to stable performance from existing plants and new facilities in the U.S.

Samsung Biologics Accelerates “Three-Pillar Expansion Strategy” With Peptide CDMO Acquisition to Drive Global Growth

Samsung Biologics acquires Polypeptide Group for $1.8 billion, expanding into the peptide CDMO market to enhance growth and capabilities.

Samsung Biologics Expands Global Reach: New European Sales Office Set to Boost Biopharmaceuticals Market

Samsung Biologics expands its global sales network with a new office in Europe, aiming for growth in production and portfolio diversification.

Samsung Biologics Highlights CRDO and Organoid Platforms at PEGS Boston

Samsung Biologics showcased its CRDO capabilities at PEGS Boston, enhancing cancer drug development with innovative organoid technology.

Samsung Biologics Named Dow Jones Best-in-Class World Index for Fifth Straight Year

Samsung Biologics has been recognized in the Dow Jones Best-in-Class World Index for five consecutive years, showcasing its ESG achievements.

Samsung Biologics Just Made a Big Move That Could Reshape Korea’s Biotech Future

Samsung Biologics reveals C-Lab Outside, a biotech innovation hub, to support startups and foster growth in Korea's biotech sector.

Samsung Biologics Wins “Sustainability Leadership” at CDMO Awards: What This Means for the Future of Biopharma

Samsung Biologics wins the Sustainability Leadership award, marking a 13-year streak and highlighting its commitment to sustainable practices.

Samsung Biologics America Achieves Record Profit: What This Means for Global Expansion in 2026

Samsung Biologics America reports record profits, showcasing its successful global expansion strategy despite previous revenue dips.

Samsung Biologics Strengthens Global Partnerships at Decat Week 2026: Key Insights and Strategies

Samsung Biologics aims to enhance global partnerships at J.P. Morgan's Healthcare Conference 2026, showcasing its CDMO strengths.

Samsung Biologics Partners with Eli Lilly: How This Open Innovation Hub Will Transform K-Bio by 2027

Samsung Biologics partners with Eli Lilly to create a biotech innovation hub in Korea, enhancing growth opportunities for local firms.

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

Samsung Biologics: How a 56 Billion USD CDMO Leader is Shaping the Future of Biopharmaceuticals

Samsung Biologics is evolving as a leading CDMO, targeting a production capacity of 1.32M liters by 2030 after its spin-off from Bioepis.

Samsung Biologics Joins CEPI: How This Partnership Will Revolutionize Vaccine Production in Asia

Samsung Biologics partners with CEPI to enhance vaccine manufacturing, aiming to strengthen global health security and support local biotech growth.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.